CD5 and melanoma: Thus, homozygous carriers of the ancestral Pro224-Ala471 (rs2241002C and rs2229177C) CD5 haplotype are hyper-reactive to TCR/CD3 cross-linking, and present more severe clinical forms of SLE (27) but better CLL and melanoma prognosis (28, 29).